Elutia Inc. SEC filings ELUT
Elutia Inc. has 369 filings in SEC EDGAR's recent list, going back to Jun 9, 2017. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 21, 2026 (acquisition or sale of assets, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Aug 21, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 7, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 20, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 16, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 9, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Other events
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Listing notice
|
Jan 2, 2026 | Dec 23, 2025 |
| 8-K |
Current report
Listing notice
|
Nov 12, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 14, 2025 | Oct 7, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure, Other events
|
Oct 7, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 9, 2025 | Sep 8, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 20, 2025 | Aug 15, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2025 | May 29, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
May 6, 2025 | Apr 30, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 4, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 3, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 3, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 18, 2024 | Jun 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 17, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 1, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 2, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 12, 2024 | Jan 10, 2024 |
| 8-K |
Current report
Other events
|
Jan 10, 2024 | Jan 10, 2024 |
| 8-K |
Current report
Other events
|
Dec 27, 2023 | Dec 27, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 8, 2023 | Dec 8, 2023 |
| 8-K |
Current report
Other events
|
Nov 20, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Nov 15, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 7, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 21, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 19, 2023 | Sep 17, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Sep 7, 2023 | Sep 6, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 13, 2023 | Jul 13, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 9, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Results of operations, Listing notice
|
May 10, 2023 | May 4, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 21, 2023 | Apr 20, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 20, 2023 | Mar 20, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 30, 2022 | Dec 23, 2022 |
| 8-K |
Current report
New debt
|
Dec 15, 2022 | Dec 13, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 5, 2022 | Nov 30, 2022 |
| 8-K |
Current report
Material agreement
|
Nov 28, 2022 | Nov 21, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 17, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 24, 2022 | Oct 20, 2022 |
| 8-K |
Current report
Material agreement
|
Oct 13, 2022 | Oct 9, 2022 |
| 8-K |
Current report
Other events
|
Aug 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Aug 15, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Listing notice, Officer or director change, Regulation FD disclosure
|
Jun 21, 2022 | Jun 20, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Listing notice
|
Jun 3, 2022 | May 27, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2022 | Mar 3, 2022 |
| 8-K |
Current report
Material agreement
|
Jan 21, 2022 | Jan 21, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 7, 2022 | Dec 30, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 8, 2021 | Dec 5, 2021 |
| 8-K |
Current report
Listing notice
|
Nov 22, 2021 | Nov 16, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Results of operations
|
Oct 25, 2021 | Oct 25, 2021 |
| 8-K/A |
Amended current report
Results of operations
|
Aug 10, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Agreement ended
|
Jul 6, 2021 | Jul 1, 2021 |
| 8-K |
Current report
Other events
|
Jun 22, 2021 | Jun 22, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2021 | Jun 7, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 7, 2021 | Jun 7, 2021 |
| 8-K |
Current report
Results of operations
|
May 4, 2021 | May 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 2, 2021 | Feb 24, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2021 | Mar 1, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 19, 2020 | Nov 19, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 13, 2020 | Oct 7, 2020 |
Showing 86 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ELUT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Silver Spring, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1708527
- Former names
- AZIYO BIOLOGICS, INC. (until Aug 14, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.